DE69818983D1 - Verfahren zur herstellung optisch aktiver imidazolverbindungen, zwischenprodukte zu ihrer herstellung und verfahren zu ihrer herstellung - Google Patents

Verfahren zur herstellung optisch aktiver imidazolverbindungen, zwischenprodukte zu ihrer herstellung und verfahren zu ihrer herstellung

Info

Publication number
DE69818983D1
DE69818983D1 DE69818983T DE69818983T DE69818983D1 DE 69818983 D1 DE69818983 D1 DE 69818983D1 DE 69818983 T DE69818983 T DE 69818983T DE 69818983 T DE69818983 T DE 69818983T DE 69818983 D1 DE69818983 D1 DE 69818983D1
Authority
DE
Germany
Prior art keywords
producing
optically active
compound
intermediate products
imidazole compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69818983T
Other languages
English (en)
Other versions
DE69818983T2 (de
Inventor
Kazuyuki Kawasaki
Haruhito Kobayashi
Syuji Ehara
Hideaki Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Publication of DE69818983D1 publication Critical patent/DE69818983D1/de
Application granted granted Critical
Publication of DE69818983T2 publication Critical patent/DE69818983T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE69818983T 1997-01-23 1998-01-14 Verfahren zur herstellung optisch aktiver imidazolverbindungen, zwischenprodukte zu ihrer herstellung und verfahren zu ihrer herstellung Expired - Fee Related DE69818983T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1011497 1997-01-23
JP09010114A JP2000290259A (ja) 1997-01-23 1997-01-23 光学活性なイミダゾール化合物の製造方法およびその合成中間体
PCT/JP1998/000150 WO1998032740A1 (fr) 1997-01-23 1998-01-14 Procede de production de composes d'imidazol opto-actifs, intermediaires aux fins de la synthese de ces composes et leur procede de production

Publications (2)

Publication Number Publication Date
DE69818983D1 true DE69818983D1 (de) 2003-11-20
DE69818983T2 DE69818983T2 (de) 2004-09-09

Family

ID=11741291

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69818983T Expired - Fee Related DE69818983T2 (de) 1997-01-23 1998-01-14 Verfahren zur herstellung optisch aktiver imidazolverbindungen, zwischenprodukte zu ihrer herstellung und verfahren zu ihrer herstellung
DE69835705T Expired - Lifetime DE69835705D1 (de) 1997-01-23 1998-01-14 Verfahren zur Herstellung von optisch aktiven Imidazolverbindungen, Zwischenprodukte zu deren Herstellung und ihre Herstellung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69835705T Expired - Lifetime DE69835705D1 (de) 1997-01-23 1998-01-14 Verfahren zur Herstellung von optisch aktiven Imidazolverbindungen, Zwischenprodukte zu deren Herstellung und ihre Herstellung

Country Status (11)

Country Link
US (2) US6066739A (de)
EP (2) EP1378507B1 (de)
JP (1) JP2000290259A (de)
KR (1) KR100490891B1 (de)
CN (1) CN1133623C (de)
AT (2) ATE252085T1 (de)
AU (1) AU5496698A (de)
CA (1) CA2278509C (de)
DE (2) DE69818983T2 (de)
ES (1) ES2209104T3 (de)
WO (1) WO1998032740A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000290259A (ja) * 1997-01-23 2000-10-17 Welfide Corp 光学活性なイミダゾール化合物の製造方法およびその合成中間体
EP1719764A1 (de) * 2004-02-27 2006-11-08 Mitsubishi Pharma Corporation Verfahren zur asymmetrischen reduktion von 4-[5-(imidazol-1-yl)-2-methylbenzoyl]-3,5-dimethylbenzoesäure oder estern davon

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5770884A (en) * 1980-10-21 1982-05-01 Kyowa Hakko Kogyo Co Ltd Novel piperidine derivative and its preparation
JPS6314771A (ja) * 1986-07-08 1988-01-21 Sankyo Co Ltd 光学活性イミダゾ−ル誘導体およびその製法
JPH02215771A (ja) * 1989-02-14 1990-08-28 Yoshitomi Pharmaceut Ind Ltd 光学活性なイミダゾール化合物の製造方法およびその合成中間体
US5656762A (en) * 1990-12-28 1997-08-12 Neurogen Corporation 4-piperidino-and piperazinomethyl-2-phenylimidazole derivatives, dopamine receptor subtype specific ligands
JP2000290259A (ja) * 1997-01-23 2000-10-17 Welfide Corp 光学活性なイミダゾール化合物の製造方法およびその合成中間体

Also Published As

Publication number Publication date
WO1998032740A1 (fr) 1998-07-30
ATE337306T1 (de) 2006-09-15
CA2278509A1 (en) 1998-07-30
EP0972768B1 (de) 2003-10-15
EP1378507B1 (de) 2006-08-23
JP2000290259A (ja) 2000-10-17
ES2209104T3 (es) 2004-06-16
EP0972768A1 (de) 2000-01-19
DE69835705D1 (de) 2006-10-05
EP0972768A4 (de) 2001-06-27
KR20000070362A (ko) 2000-11-25
CN1133623C (zh) 2004-01-07
US6166221A (en) 2000-12-26
AU5496698A (en) 1998-08-18
CN1251093A (zh) 2000-04-19
EP1378507A3 (de) 2004-02-04
CA2278509C (en) 2007-03-20
US6066739A (en) 2000-05-23
ATE252085T1 (de) 2003-11-15
DE69818983T2 (de) 2004-09-09
EP1378507A2 (de) 2004-01-07
KR100490891B1 (ko) 2005-05-24

Similar Documents

Publication Publication Date Title
CY1112350T1 (el) Διαδικασια παραγωγης ενος οπτικα ενεργου οξοεπτενοϊκου οξινου εστερα
ATE157647T1 (de) Verfahren zur herstellung von alpha- ketoamidderivaten
DE69818983D1 (de) Verfahren zur herstellung optisch aktiver imidazolverbindungen, zwischenprodukte zu ihrer herstellung und verfahren zu ihrer herstellung
ATE252594T1 (de) Verfahren zur herstellung von ribavirin
EP0937703A4 (de) Verfahren zur reinigung von brenztraubensäureverbindungen
EP1460065A4 (de) Verfahren zur herstellung von cyclischen diaminverbindungen bzw. deren salzen
DE69622862D1 (de) Verfahren zur herstellung von zyklischen verbindungen
ATE201410T1 (de) Verfahren zur herstellung von 1-(4,5-dihydro)2- thiazolyl-3-azetidinthiolderivaten
DE60232308D1 (de) Verfahren zur herstellung von fluorinverbindungen
DE50209490D1 (de) Verfahren zur herstellung von zolpidem
ATE411978T1 (de) Verfahren zur herstellung von alpha-aminoketonen
HU208525B (en) Direct process for producing captopril
DE69629661D1 (de) VERFAHREN ZUR HERSTELLUNG VON N-(D-alpha-METHYL-beta-MERCAPTOPROPIONYL)-L-PROLIN UND INTERMEDIATEN DAVON
ATE460383T1 (de) Verfahren zur herstellung von stickstofftrifluorid
ATE236909T1 (de) Verfahren zur herstellung von phosphorohalidaten
DE50101761D1 (de) Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl-essigsäure
DE60239793D1 (de) Verfahren zur herstellung von 7-chinolinyl-3,5-dihydroxyhept-6-enoat
ATE425972T1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
ATE555089T1 (de) Verfahren zur herstellung von -ketoacetalen
ATE179417T1 (de) Glyceraldehyd-3-pentanid und verfahren zu ihrer herstellung
CA2185956A1 (en) Method of Purifying 1,3-Bis(3-Aminopropyl)-1,1,3,3-Tetraorganodisiloxane
ATE341642T1 (de) Verfahren zur herstellung von d- asparaginderivaten
EP1489066A4 (de) Verfahren zur herstellung von optisch aktiver carbonsäure
JPS6445336A (en) Production of 2-(r)-hydroxy-4-phenyllactic acid derivative

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee